C
Cheetah Medical
Cheetah Medical is a device company developing non-invasive cardiac output and hemodynamic monitoring devices
About Cheetah Medical
Cheetah Medical, now a part of Baxter International, is a healthcare technology company specializing in noninvasive hemodynamic monitoring systems. Their flagship product, the Cheetah Starling SV Hemodynamic Monitoring System, provides real-time data on a patient's cardiovascular health by measuring blood flow and heart function without the need for invasive procedures. This technology is particularly valuable for managing fluid therapy in patients, ensuring that intravenous (IV) fluids are administered effectively to optimize cardiac output and overall patient outcomes.
Read full description
The company primarily serves hospitals and healthcare providers, focusing on critical care units where precise fluid management is crucial. Their technology is applicable across a wide range of patient populations receiving IV fluids, making it a versatile tool in various clinical settings.
Cheetah Medical operates in the medical devices market, which is a rapidly growing sector driven by advancements in healthcare technology and an increasing emphasis on patient safety and outcomes. Their business model revolves around the sale and leasing of their monitoring systems, as well as providing ongoing support and education to healthcare professionals. Revenue is generated through the direct sale of devices, recurring leasing fees, and potentially through service contracts for maintenance and training.
By improving the accuracy of fluid management, Cheetah Medical's technology helps hospitals reduce complications, shorten ICU stays, and ultimately save on healthcare costs. This economic benefit, combined with improved patient care, positions Cheetah Medical as a valuable partner for healthcare institutions aiming to enhance their clinical outcomes.
At a glance
- Status
- Acquired
- Founded
- 2001
- Headquarters
- Tel Aviv-Yafo, Israel
- Employees
- 33
- Open positions
- None listed
- Dealroom signal
- 36.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Risk Management, Biotechnology, Decision Making, Surgery, Cardiology and cardiovascular, Critical medical care, Non-Invasive medical devices and treatments, Spinout, Tech for Hospitals and Clinics, Clinical Decision Support, DT and LS
Latest news
Press, funding announcements and product moves mentioning Cheetah Medical.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2019 | $230M | $230M | Baxter International | — |
| EARLY VCOther financing | Apr 2018 | $7M | $28M | Undisclosed | — |
Growth signals
Latest recorded traffic for Cheetah Medical is 820 monthly website visits. Cheetah Medical's team declined 25% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 FeopsCutting-edge technology that creates digital twins from cardiac scans |
Ghent, Belgium | Acquired | 35 | $12M | $26M |
 CroivalveTreating Heart Valve Disease |
Dublin, Ireland | Operational | |||
 miDiagnosticsSilicon chip diagnostics for rapid, lab-quality results |
Leuven, Belgium | Operational | |||
 CapreolosHealth-tech company that provides application in which patients can get prepared before surgical procedures |
Bad Vilbel, Germany | Operational | |||
 ANTERIOSInnovative biopharmaceutical solutions tackling the toughest health challenges with a focus on impactful treatments |
New York City, United States | Acquired | |||
 SurgeInnovative fingerprinting of the immune system with AI to holistically improve the perioperative standard-of-care |
Paris, France | Operational | |||
 InnitiusCervical Consistency + AI for improved accuracy in Birth Timing |
Derio, Spain | Operational | |||
 KribaNon-invasive screening and monitoring of serous fluids infections of the body |
Madrid, Spain | Operational |
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Bosch Ventures
Ascension
MVM Life Science Partners
Series B and later1 investor entered at this stage
- HPHighCape Partners
Other known investors2 additional known investors
Baxter International
Weizmann Institute of Science
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cheetah Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cheetah Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.